鹏源药业 (870253.OC)

+ 收藏

利润表(鹏源药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 464,885,613.77962,973,083.53461,136,858.94880,400,798.89397,194,269.03
 营业收入(元) 464,885,613.77962,973,083.53461,136,858.94880,400,798.89397,194,269.03
二、营业总成本(元) 462,144,140.77953,099,132.39452,820,707.46845,017,604.80385,859,337.56
 营业成本(元) 418,222,447.10850,767,678.48401,269,187.82770,192,817.61355,742,854.11
 营业税金及附加(元) 820,234.991,680,317.55730,415.451,401,970.15590,660.21
 销售费用(元) 35,836,372.1086,110,822.9943,732,167.2662,322,733.2024,471,644.70
 管理费用(元) 6,584,016.6713,314,507.306,486,214.639,948,594.074,555,593.38
 财务费用(元) 681,069.911,225,806.07602,722.301,151,489.77498,585.16
  其中:利息费用(元) 678,571.181,130,444.39569,129.30946,187.82243,985.00
  其中:利息收入(元) -183,273.45408,820.33-216,920.56229,458.86-81,487.01
三、其他经营收益
 资产处置收益(元) -130,341.36-131,306.20-66,073.8853,148.20-9,602.80
 资产减值损失(元) --2,100,781.47--3,053,031.58-
 信用减值损失(元) -4,774.55-55,928.9580,212.09-614,391.68-180,416.02
 其他收益(元) 27,630.2878,928.3723,053.4764,385.453,165.99
四、营业利润(元) 2,633,987.377,664,862.898,353,343.1631,833,304.4811,148,078.64
 加:营业外收入(元) -300.00313.642,886.008,623.75
 减:营业外支出(元) 5,647.48112,839.65-84,785.8638,875.26
五、利润总额(元) 2,628,339.897,552,323.248,353,656.8031,751,404.6211,117,827.13
 减:所得税费用(元) 619,145.912,311,812.922,108,511.076,459,208.271,414,863.18
六、净利润(元) 2,009,193.985,240,510.326,245,145.7325,292,196.359,702,963.95
(一)按经营持续性分类
  持续经营净利润(元) 2,009,193.98-6,245,145.7325,292,196.359,702,963.95
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 2,009,193.985,240,510.326,245,145.7325,292,196.359,702,963.95
 扣除非经常性损益后的净利润(元) 2,090,462.905,370,240.226,277,175.8125,266,773.389,730,480.19
七、每股收益
 一、基本每股收益(元) 0.040.090.110.460.18
 二、稀释每股收益(元) 0.040.090.110.460.18
九、综合收益总额(元) 2,009,193.985,240,510.326,245,145.7325,292,196.359,702,963.95
 归属于母公司所有者的综合收益总额(元) 2,009,193.985,240,510.326,245,145.7325,292,196.359,702,963.95
公告日期 2024-08-282024-04-252023-08-252023-04-202022-08-29
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院